-
Roche SARS-CoV-2 Molecular Test Gets FDA Emergency Use Authorization for PCR Testing of both Symptomatic and Asymptomatic Individuals
americanpharmaceuticalreview
June 23, 2021
The cobas SARS-CoV-2 test is the first RT-PCR test that screens within 20 minutes both asymptomatic and symptomatic persons, enabling quick, informed decisions at the point of care.
-
Thermo Fisher Scientific Expands SARS-CoV-2 Testing Portfolio in India with Point-of-Care Testing Platform.
expresspharma
June 18, 2021
The Accula System is an innovative platform that will accelerate the availability of reliable and accurate advanced molecular diagnostics at the point of care.
-
COVID Rapid Test Confirms Presence of Antibodies
prnewswire
June 16, 2021
A U.S. clinical trial of a COVID-19 rapid test approved by an institutional review board found the Specificity of confirmed negative Covid-19 patients by RT-PCR was 100% (95% CI, 88.4%-100.0%).
-
Affinity Empowering Launches "Operation Expanded Testing" in Agreement with U.S. Government to Increase COVID-19 Testing
prnewswire
June 11, 2021
Affinity today announced the launch of Operation Expanded Testing, a program to increase COVID-19 testing capabilities throughout congregate settings including K-8 schools and summer school programs, correctional facilities, homeless shelters, and select
-
COVID-19 trials and tribulations for treatments
expresspharma
May 24, 2021
COVID-19 has impelled the scientific community to research and develop new therapies to counter a serious viral pandemic. Since 2020, many old drugs repurposed as treatment for COVID-19 have been studied in clinical trials to assess efficacy and safety.
-
Private genomics industry may be called upon to speed up strategic genome surveillance initiatives
expresspharma
April 06, 2021
How has the COVID-19 pandemic reinforced the value and significance of genomic surveillance? How can it play a critical role in making the world more informed and adept at preventing and curtailing future epidemics and pandemics?
-
EU authorisation for XPhyto’s rapid COVID-19 PCR test
pharmatimes
March 19, 2021
XPhyto Therapeutics and its diagnostics development partner 3a-diagnostics GmbH have received EU approval for their COVID-19 RT-PCR test system – Covid-ID Lab.
-
Vivera Pharmaceuticals and Burkhan Group Announce New COVID-19 Testing Initiative
prnewswire
January 26, 2021
Vivera Pharmaceuticals, in partnership with Burkhan Group, is excited to announce a new testing initiative in Southern California.
-
Novel COVID-19 test could significantly reduce testing time
europeanpharmaceuticalreview
January 06, 2021
The new COVID-19 test, called RTF-EXPAR, was able to accurately detect the presence of SARS-CoV-2 viral RNA in under five minutes.
-
INEX Innovate's CORO(TM) Real-Time RT-PCR SARS-CoV-2 Kit for the detection of COVID-19 obtains Singapore's Health Sciences Authority Provisional Authorisation
prnasia
December 30, 2020
INEX Innovate Pte Ltd a Singapore based molecular diagnostics developer announced that the Singapore Health Sciences Authority has issued provisional authorisation to the company's CORO™ Real-Time RT-PCR SARS-CoV-2 for the diagnosis of COVID-19.